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An extra copy of chromosome 21 causes Down syndrome, the
most common genetic disease in humans. The mechanisms con-
tributing to aneuploidy-related pathologies in this syndrome, in-
dependent of the identity of the triplicated genes, are not well
defined. To characterize aneuploidy-driven phenotypes in trisomy
21 cells, we performed global transcriptome, proteome, and phe-
notypic analyses of primary human fibroblasts from individuals
with Patau (trisomy 13), Edwards (trisomy 18), or Down syn-
dromes. On average, mRNA and protein levels were increased by
1.5-fold in all trisomies, with a subset of proteins enriched for
subunits of macromolecular complexes showing signs of posttran-
scriptional regulation. These results support the lack of evidence
for widespread dosage compensation or dysregulation of chromo-
somal domains in human autosomes. Furthermore, we show that
several aneuploidy-associated phenotypes are present in trisomy
21 cells, including lower viability and increased dependency on
serine-driven lipid synthesis. Our studies establish a critical role
of aneuploidy, independent of triplicated gene identity, in driving
cellular defects associated with trisomy 21.
Down syndrome | aneuploidy | sphingolipids | dosage compensation |
trisomy 21
An abnormal number of chromosomes or aneuploidy ac-counts for most spontaneous abortions, as missegregation of
a single chromosome during development is often lethal (1, 2).
Individuals with trisomies of chromosomes 13 or 18, which cause
Patau and Edwards syndromes, respectively, are born with severe
developmental defects and die soon after birth. Only individuals
with trisomy 21, which causes Down syndrome, can live to adult-
hood. However, they display developmental abnormalities, cognitive
disabilities, congenital heart defects, increased risk for leukemias and
neurodegenerative disease, autoimmune disorders, and clinical
symptoms associated with premature aging (3, 4). The incidence of
aneuploidy is also associated with tumorigenesis and increases with
age in both somatic and germline tissues in apparently healthy in-
dividuals (5, 6). The mechanisms by which aneuploidy affects cel-
lular function to cause Down syndrome, promotes tumor formation,
or promotes aging are not well understood.
The phenotypes associated with trisomy 21 at the organismal
level are complex. Indeed, individuals with Down syndrome are
born with varying severities and higher risks for several human
diseases (4). Two main gene-centric hypotheses have been pro-
posed to explain the biological consequences of trisomy 21. One
is that increased expression of a particular gene and its down-
stream effectors cause the pathophysiology in Down syndrome.
For example, increased expression of the amyloid-beta precursor
protein (APP), the High Mobility Group Nucleosome Binding
Domain 1 (HMGN1), or the transcription factor RUNX1 are
associated with the increased incidence of early onset of Alzheimer’s
disease, B cell acute lymphoblastic leukemia, or transient myelo-
proliferative disorder in individuals with Down syndrome, re-
spectively (7–9). A second hypothesis is that abnormalities arise
due to the indirect effects of increased gene activity on chromo-
some 21 that alter specific cellular processes. Examples include
genes that regulate splicing (U2AF1L5, RBM1, and U2AF1), chro-
matin regulators (HMGN1 and BRWD1), secretory-endosomal
functions (DOPEY2, CSTB, and SYNJ1), protein turnover (USP25),
or metabolism (SOD1). Nonetheless, it has been challenging to
prove that a third wild-type copy of a given gene on chromosome
21 is the sole driver of a particular disease (3, 4). Indeed, analysis
of human segmental trisomies of chromosome 21 provides evi-
dence against the existence of a single chromosomal region con-
tributing to Down syndrome phenotypes (10).
A third, less well-explored consequence of trisomy 21 is the
disruption of cellular physiology due to the presence of an extra
chromosome independent of the identity of the triplicated genes
(i.e., the aneuploid status of the cell). Several studies have
revealed aneuploidy-driven phenotypes shared among different
organisms that are independent of the abnormal karyotype (11,
12). These include defects in cell proliferation, signs of proteotoxic
stress, genomic instability, and altered metabolism. We recently
showed in both yeast and human cells that the presence of an extra
copy of a chromosome disrupts nuclear morphology (13). This
phenotype is associated with dysregulation of the synthesis of
lipids that constitute the nuclear membrane. In particular, we
found that increasing the levels of long-chain bases suppresses
nuclear abnormalities and improves the fitness of aneuploid cells,
including human fibroblasts with trisomy 21 (13, 14).
Significance
An abnormal number of chromosomes or aneuploidy accounts
for most spontaneous abortions, as missegregation of a single
chromosome during development is often lethal. Only indi-
viduals with trisomy 21, which causes Down syndrome, can live
to adulthood but show cognitive disabilities, increased risk for
leukemias, autoimmune disorders, and clinical symptoms as-
sociated with premature aging. The mechanisms by which an-
euploidy affects cellular function to cause Down syndrome are
not understood. Our studies revealed that aneuploidy causes
several defects in cells from individuals with Down syndrome.
These include increased gene and protein expression, lower
viability, and increased dependency on serine to proliferate.
Our studies establish a critical role of aneuploidy, independent
of triplicated gene identity, in driving cellular defects associated
with trisomy 21.
Author contributions: S.H., P.C., N.D., and E.M.T. designed research; S.H., P.C., R.L., N.D.,
and E.M.T. performed research; S.H., P.C., R.L., L.J.Z., N.D., and E.M.T. analyzed data; and
E.M.T. wrote the paper.
The authors declare no competing interest.
This article is a PNAS Direct Submission.
This open access article is distributed under Creative Commons Attribution-NonCommercial-
NoDerivatives License 4.0 (CC BY-NC-ND).
1To whom correspondence may be addressed. Email: Eduardo.Torres@umassmed.edu.
This article contains supporting information online at https://www.pnas.org/lookup/suppl/
doi:10.1073/pnas.2014723118/-/DCSupplemental.
Published February 1, 2021.














































To further characterize aneuploidy-associated phenotypes in
human cells, we performed a global transcriptome and proteome
quantification in primary fibroblasts isolated from individuals
with Down, Edwards, or Patau syndromes. We found that several
aneuploidy-associated phenotypes are present in primary fibro-
blasts with trisomy 21. These include lower viability, altered lipid
metabolism, and an increased dependency on serine to proliferate.
Altogether, these studies demonstrate that, in addition to the gene-
driven pathologies associated with Down syndrome, aneuploidy-
related cellular defects that are independent of chromosome 21 gene
identity can contribute to disease.
Results
Transcriptome Analyses of Primary Fibroblasts Show a Proportional
Relationship between Copy Number and Transcript Levels. Several
studies have suggested a complicated relationship between copy
number, messenger RNA (mRNA), and protein levels of genes
located on chromosome 21 (15–18). It has been proposed that
gene dosage compensation can ameliorate the expression levels
of genes located on triplicated chromosomes, yet the mecha-
nisms for this process remain unclear (19). Furthermore, it is
thought that an extra copy of chromosome 21 has a significant
impact on the rest of the genome, causing dysregulation of ex-
pression of defined chromosomal domains (16). To test these
hypotheses, we initially focused on quantifying the mRNA changes
of the genes expressed on trisomic human chromosomes in primary
fibroblasts. We obtained from the Coriell Institute 2 cell lines with
trisomy 13, 2 with trisomy 18, 7 with trisomy 21, and 6 euploid
controls, resulting in a total of 17 cell lines (SI Appendix, Fig. S1A).
All cell lines were grown in the standard cell culture growth
conditions, and samples were split into two for transcriptome
and proteome quantifications. RNA sequencing (RNAseq) of
the transcriptomes provided quantitative information for 10,717
genes across all 17 samples (Fig. 1A and Dataset S1). We calcu-
lated the log2 of the fold changes (FC) for all 17 samples using the
average expression of the six controls as the reference genome.
We obtained log2 ratios for 92, 145, and 183 genes on chromo-
somes 21, 18, and 13, respectively (Fig. 1B). We found that, on
average, the triplicated chromosomes in all 11 analyzed trisomic
cell lines displayed a 1.5-fold increase (3/2 copies, log2 FC = 0.58)
in gene expression, consistent with an absence of dosage com-
pensation (Fig. 1B and SI Appendix, Fig. S1B).
The values of the average log2 ratios of the triplicated genes fit
a normal distribution with means of 0.6 and SDs of 0.24, 0.27,
and 0.14 for trisomies 13, 18, and 21, respectively (Tri 13, 18, and
21, Fig. 1 C–E). The average log2 ratios of the same genes in the
cell lines that harbor two copies also fit a normal distribution
with means of 0.0 and SDs of 0.10 to 0.11 (not Tri 13, 18, or 21,
Fig. 1 C–E). Although the log2 ratios of the triplicated genes also
fit a normal distribution quite well (R2 between 0.91 and 0.98),
few genes fall outside the Gaussian fits (outlier genes), as their
expression does not seem to increase with copy number. Closer
inspection of the normalized transcript counts (transcript per
million, TPM) of the outliers in each distribution revealed that
their expression levels were highly variable across individual cell
lines, including the six euploid control cell lines (Fig. 1F and SI
Appendix, Fig. S1C). For example, one outlier on chromosome
13 is KCTD12, a gene whose expression varies up to 12-fold
among cell lines and up to sevenfold in the two different triso-
mies 13. The levels of the transcription factor GATA6 located on
chromosome 18 vary up to 15-fold among cell lines not trisomic
for chromosome 18. COL18A1 and RIPK4 are the main outliers
in trisomy 21 and show, respectively, ninefold and 19-fold vari-
ability among control cell lines. Indeed, the few outliers of the
distributions of triplicated genes, including below or above the
fits, show high variability in expression among different individ-
uals (SI Appendix, Fig. S1C). Our analysis indicates that, on av-
erage, most genes located on the trisomic chromosomes increase
1.5-fold in expression and that interindividual variability in gene
expression accounts for a couple of outliers in the dataset.
Although several recent studies quantified the transcriptome
of trisomy 21 cells, they did not report a precise quantification
and analyses of the mRNA levels of genes located on chromosome
21. To validate that the transcript levels of chromosome 21 genes
proportionally increase with copy number, we analyzed two re-
cently published datasets, one by Sullivan et al. (20) and the other
by Letourneau et al. (16). In a tour de force approach, Sullivan
et al. obtained transcriptome profiles of 24 human Telomerase
reverse transcriptase (hTERT)-immortalized fibroblasts, 12
transformed B cells (lymphoblastoid cell lines, LCLs), 17 mono-
cytes, and 17 T cell lines from different individuals with normal
karyotype or with Down syndrome (SI Appendix, Fig. S2A). We
calculated the log2 of the FC using the average expression of the
control individuals as the reference genome for each cell type and
plotted the data ordered by chromosome position (Fig. 2A and
Dataset S2). Consistent with our analysis of primary fibroblasts, we
found that, on average, the mRNA levels of genes located on
chromosome 21 are 1.5-fold higher in all cell types and across
samples from different individuals with Down syndrome relative to
the controls (Fig. 2B). As observed in our data, a few outlier genes
that do not fit the normal distributions can be accounted for by high
variability in expression levels among control individuals (SI Ap-
pendix, Fig. S2C). Intriguingly, one fibroblast cell line (T21.1b)
shows significant changes in gene expression in all chromosomes
and deviates from the rest. We suspect that technical issues may
account for such extreme changes in gene expression across the
genome in this sample (see below). Altogether, the transcript
levels of chromosome 21 genes in 37 out of 38 cell lines with
trisomy 21 analyzed by Sullivan et al. fit a normal distribution with
means very close to the predicted log2 ratio of 0.58 (Fig. 2C).
In the second study, Letourneau et al. reported the expression
profiles of primary fibroblasts from 16 unrelated individuals (8
controls and 8 with trisomy 21) and of two cell lines obtained
from monozygotic twins, one with a normal karyotype and the
other with trisomy 21 (SI Appendix, Fig. S2B). Consistently, we
found, on average, a 1.5-fold increase in expression of chromo-
some 21 genes in the primary fibroblasts from individuals with
Down syndrome (Fig. 2 D and E). On the other hand, the
monozygotic twin with trisomy 21 shows very variable expression
across the genome (Fig. 2 D and E and Dataset S2). Letourneau
et al. interpreted the latter result as evidence for trisomy 21
driving the dysregulation in expression across chromosomal do-
mains. A closer inspection of the transcript counts raises the
possibility that technical issues account for this result. We found
that the correlation of gene expression among biological repli-
cates of the same cell line from the monozygotic twin with tri-
somy 21 is low (R2 = 0.44, SI Appendix, Fig. S2E) compared to
the correlation between two different primary fibroblasts (R2 =
0.95, SI Appendix, Fig. S2D). We also found that up to 27% of
the total reads in the RNAseq datasets of the monozygotic twins
come from mitochondrial DNA–encoded genes (SI Appendix,
Fig. S2F). The poor reproducibility of the monozygotic twins’
transcriptomes seems to be caused by low gene coverage. The
total read counts of the monozygotic twins’ genome are about
half of the coverage of primary fibroblasts (SI Appendix, Fig.
S2F). Indeed, only ∼4,000 genes show 1 read per kilobase million
or greater values in the monozygotic twin dataset compared to
more than 10,000 in the primary fibroblasts (SI Appendix, Fig.
S2G). Unexpectedly, the average gene expression per chromo-
some of the outlier sample from the Sullivan et al. study (T21.1b)
shows similar expression patterns but opposite values than the
monozygotic twin trisomy 21 (SI Appendix, Fig. S2E). This
analysis raises the possibility that similar technical issues may
account for these very variable transcriptomes. Excluding the two
outlier transcriptomes, our analyses support the hypothesis that,
on average, the mRNA levels increase proportionally with gene
2 of 12 | PNAS Hwang et al.







































copy numbers. Mechanisms to compensate and ameliorate gene
expression of an extra copy of a human autosome do not seem to
be engaged.
Interindividual Variability Drives Gene Expression Patterns of Human
Primary Fibroblasts. Similar to the findings reported by Sullivan
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Fig. 1. Transcript levels increase proportionally with gene copy number in trisomic primary fibroblasts. (A) The gene expression of 17 primary fibroblast cell
lines ordered by chromosome position. The experiments (columns) for each cell line are shown. T13 = trisomy 13, T18 = trisomy 18, T21 = trisomy 21, and
Con = euploid control; refer to SI Appendix, Fig. S1A for detailed cell line nomenclature. (B) The average gene expression per chromosome was calculated for
each cell line. The number of genes quantified per chromosome is shown in the right of the heat map. Chromosomes 21, 18, and 13 represent 0.86%, 1.35%,
and 1.71% of the total transcriptome, respectively. (C) A histogram of the average log2 ratios of the RNA copy number of genes located on euploid chromosomes
(Left) and genes present on trisomic chromosome 13 (Right) in cell lines GM00526 and GM02948, relative to euploid controls, are shown. (D) A histogram of the
average log2 ratios of the RNA copy number of genes located on euploid chromosomes (Left) and genes present on trisomic chromosome 18 (Right) in cell lines
GM00734 and GM03538, relative to euploid controls are shown. (E) A histogram of the average log2 ratios of the RNA copy number of genes located on euploid
chromosomes (Left) and genes present on trisomic chromosome 21 (Right) in cell lines GM04616, GM04592, AG05397, AG06922, GM02767, AG08941, and
AG08942, relative to euploid controls are shown. In C–E, the bin size for all histograms is log2 ratio of 0.2 and medians are identical to means. Fits to a normal
distribution (black line), means, SD, and goodness of fit (R2) are shown for each distribution. (F) Examples of the normalized TPM of a couple of triplicated genes
that are outliers in the fits of the normal distributions. Black, red, blue, and gray bars correspond to expression in trisomy 13, 18, 21, and controls, respectively.
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Fig. 2. Transcript levels increase proportionally with gene copy number in distinct trisomy 21 cell lines. (A) The gene expression of 24 immortalized fibroblast
cell lines, 17 monocytes cell lines, 12 LCLs, and 17 T cell lines obtained by Sullivan et al. (20). The experiments (columns) for each cell line are shown ordered by
chromosome position. Refer to SI Appendix, Fig. S2A for detailed cell line nomenclature. (B) The average gene expression per chromosome was calculated for
each cell line. (C) A histogram of the average log2 ratios of the RNA copy number of genes located on euploid chromosomes (Top) and genes present on
trisomic chromosomes (Top) of the trisomic cell lines relative to euploid controls are shown. The bin size for all histograms is log2 ratio of 0.2, and medians are
identical to means. Fits to a normal distribution (black line), means, SD, and goodness of fit (R2) are shown for each distribution. (D) The gene expression of 16
primary fibroblast and 4 technical replicates of each of 2 (MZ and MZ.T21) primary fibroblasts from monozygotic twins; data obtained by Letourneau et al.
(16). The experiments (columns) for each cell line are shown ordered by chromosome position. Refer to SI Appendix, Fig. S2B for detailed cell line nomen-
clature. (E) The average gene expression per chromosome was calculated for each cell line (D).
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fibroblasts do not cluster with karyotype, sex, or the donor’s age
in all three datasets (Fig. 3A). Excluding chromosome 21, we
could not identify a set of genes that are commonly up- or down-
regulated in all three datasets. Instead, hierarchical clustering
analysis indicates that several control cell lines have gene expression
patterns closer to those of a trisomic cell line than another control.
These results suggest that gene expression patterns are specific to
the cell’s identity coming from different individuals, thereby causing
significant variability and occluding the identification of gene re-
sponses associated with aneuploidy in this context.
To better define the source of variability in gene expression
among primary fibroblasts, we analyzed the identity of genes
uniquely expressed in individual cell lines. Initially, genes whose
expression level was not detected (zero reads) in several cell lines
were omitted as part of our cutoff to calculate FC among all
samples. We found a total of 2,543 that were significantly
expressed in specific cell lines but not detected in others (Dataset
S3). Rather than calculating ratios, we normalized the relative
TPM across genes from no reads to maximum reads on a range
from 0 to 1 (0 is in black, 1 is in yellow, Fig. 3B). Hierarchical
clustering revealed a set of genes specifically expressed in each cell
line. We identified 17 clusters representing 17 cell lines. Re-
markably, the clustering pattern among the uniquely expressed
genes in the cell lines is similar to the clustering pattern of their
whole transcriptome (Fig. 3 A and B). Gene ontology enrichment
analyses revealed that this set of genes includes several master
transcription factors that determine the anatomical structure and
regulate development, including homeobox and forkhead box
genes (Fig. 3 C and D). Several membrane transporters and re-
ceptors are present in this set of genes. These results indicate that
cell identity, including anatomical and developmental properties
specific to each individual, governs the gene expression patterns of
primary fibroblasts in both trisomic and euploid cell lines.
Other sources of variability in gene expression come from culture
conditions. We found that biological replicates of the same cell line
cultured in parallel show good reproducibility (linear regression fit,
slope = 1.0 and R2 = 0.97, SI Appendix, Fig. S3B). However, when
we compared the gene expression of the same cell lines grown
months apart using independent medium preparations, hierarchical
clustering patterns were influenced by the time the cultures were
performed (SI Appendix, Fig. S3 C and D). These results indicate
that, in addition to cell identity, distinct growth conditions can sig-
nificantly contribute to physiological noise in gene expression, per-
haps fueling the discrepancies between different research groups.
Despite interindividual variability, we sought to determine
whether a set of genes change expression in response to aneu-
ploidy or trisomy 21 in our dataset. Using hierarchical clustering
analyses, we identified a set of commonly down-regulated genes
in 7 out of 11 trisomic cell lines (SI Appendix, Fig. S3A). This
cluster is enriched for genes that regulate metabolic processes,
including amino acid metabolism (P = 6.8 × 10−6) and response
to nutrient levels (P = 7.1 × 10−7). These results support the
hypothesis that aneuploidy disrupts cellular metabolism. Next, by
sorting the average change in gene expression between aneuploids
compared to euploids, we also identify a set of up-regulated genes
in trisomic fibroblasts. The up-regulated cluster is enriched for
genes in the DNA repair pathway (P = 6.2 × 10−21), consistent with
aneuploidy-causing replication stress and genomic instability. It is
noteworthy that Sullivan et al. found that trisomy 21 fibroblasts
display a gene expression pattern associated with an activated
immune response driven by interferon signaling (20), a result not
observed in the analysis of our dataset. Furthering these discrep-
ancies, Letourneau et al. reported another distinct signature as-
sociated with reduced expression of secreted proteins involved in
cytokine–cytokine receptor pathways and inflammatory response
(16). Altogether, the three studies revealed different sets of genes
that might be regulated by trisomy 21 without reaching a con-
sensus on a conserved cellular response. Several other studies have
reported different cellular pathways to be affected by trisomy 21
(21–23). We conclude that interindividual variability and experi-
mental conditions mask gene expression patterns that might be
associated with cellular responses associated with aneuploidy.
Protein Levels Increase Proportionally with Gene Copy Number and
mRNA Levels. Next, we analyzed how changes in mRNA levels
modify the proteome. We used isobaric tandem mass tag (TMT)-
based quantitative mass spectrometry (MS) to quantify protein
levels in primary fibroblasts. We analyzed two sets of 10 samples
using a TMT 10plex protocol. One control (Con.1) was analyzed
in duplicate in both sets of samples to monitor our approach’s
technical variability. Also, samples for one trisomy 21 cell line
(T21.1) were included in both sets of quantifications to test re-
producibility. We obtained quantitative information for 7,273
proteins and 7,297 proteins in the first and second sets of anal-
ysis, respectively, with 6,486 proteins overlapping (Fig. 4A and
Dataset S4). A total of five controls, two trisomies 13, two tri-
somies 18, and seven trisomies 21 proteomes were obtained in
our analysis. A comparison of the peptide counts of the two
control samples (Con.1a and Con.1b) shows good reproducibility
with a linear correlation of slope equal to 1 (R2 = 0.99), while the
comparison of the proteomes of two unrelated individuals shows
more variability (R2 = 0.81, Fig. 4B).
We then calculated the log2 of the FC using the average counts
of the control samples as the reference proteome in each dataset.
Increases in protein levels readily reveal the identities of the
triplicated chromosomes by plotting the proteome profiles for
each cell line ordered by chromosome position (Fig. 4A).
Changes in RNA and protein levels correlate with coefficients
(Pearson r) ranging from 0.4 to 0.7 among all samples analyzed
(examples for six pairs of transcriptomes and proteomes of tri-
somic cells are shown in Fig. 4C). Proteome profiles could easily
be matched to their corresponding RNA profiles using correlation
analysis between log2 ratios of RNA and protein in all samples
(SI Appendix, Fig. S4A). A total of 129, 110, and 73 proteins on
chromosomes 13, 18, and 21, respectively, were quantified in the
first dataset. A total of 76 proteins on chromosome 21 were
quantified in the second set. On average, the protein levels of the
triplicated chromosomes increase by log2 ratios of 0.45, 0.43, and
0.40 in trisomies 13, 18, and 21, respectively (SD between 0.3 to
0.5, Fig. 5 A and B). These results imply that protein levels pro-
portionally increase with copy number but are slightly lower (1.3-
to 1.4-fold) than the theoretical 1.5-fold increase observed in
transcript levels. The distributions of the log2 ratios fit quite well a
normal distribution (R2 between 0.90 and 0.98) with a couple of
outliers both below and above the curve. As observed in the
transcript levels, closer inspection of the outliers indicates that
interindividual variability accounts for their apparent dysregula-
tion (a few examples are shown in SI Appendix, Fig. S4B).
Subunits of Macromolecular Complexes Are Regulated Posttranscriptionally.
To better understand why the fold increase of the average pro-
tein levels of triplicated chromosomes is slightly lower than the
predicted 1.5-fold, we analyzed the identity of a set of proteins
encoded on the triplicated chromosomes with lower levels than
expected in the trisomic cell lines. Excluding the outliers caused
by interindividual variability, we found that about one-third of
triplicated genes (97 out of 281) have protein changes of log2
ratios less than 0.3 and fit a normal distribution with a mean of
0.13 (SD = 0.16, Fig. 5C). Remarkably, the average change in
mRNA levels of this set of proteins is 1.5-fold (mean log2 ratio =
0.55, Fig. 5C). These results indicate that the levels of this set of
proteins are attenuated via posttranscriptional mechanisms. The
other 184 triplicated genes show the predicted average increase
of 1.5-fold in both mRNA and protein levels (Fig. 5C).
Several studies showed that a set of attenuated proteins in
aneuploid yeast and mammalian cell lines include subunits of
Hwang et al. PNAS | 5 of 12
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Fig. 3. Interindividual variability drives gene expression patterns of human primary fibroblasts. (A) The hierarchical clustering analysis of the expression
patterns of primary fibroblasts analyzed in this study and in the studies by Sullivan et al. (20) and Letourneau et al. (16) are shown. The expression patterns
cluster independent of the karyotype of the cell line. (B) The relative gene expression of genes uniquely expressed in some cell lines. The hierarchical
clustering analysis revealed 17 clusters specific for each cell line. (C) The gene ontology enrichment analysis shows that the uniquely expressed genes are
enriched in master transcription factors that regulate development and cell surface markers, including transmembrane transporters and receptors proteins.
(D) Examples of the normalized TPM of a couple of genes highly expressed in some cell lines but poorly expressed in others. Black, red, blue, and gray bars
correspond to expression in trisomy 13, 18, 21, and controls, respectively.
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macromolecular complexes (24–27). We hypothesized that protein
instability of individual subunits in the absence of the up-regulation
of entire complexes is the cause of this effect (26). Here, we
found that 39% (38 of 97) of attenuated proteins are subunits of
macromolecular complexes. Notably, two out of two ribosomal
subunits in our dataset show attenuation, consistent with the
finding that ribosomal subunits are rapidly degraded unless they
assemble into a stable complex (26, 28, 29). Other examples
include two subunits of the ATPase synthase and two subunits of
NADH dehydrogenase (Fig. 5D). We also found that several
membrane proteins and secreted proteins account for the at-
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Fig. 4. Protein levels proportionally increase with copy number in trisomic fibroblasts. (A) A comparison of the mRNA (Left) and protein levels (Right) of
human primary fibroblasts. The genes are ordered by chromosome position in each experiment (columns). (B) A linear regression analysis of protein counts in
technical replicates of a control cell line and between two cell lines from different individuals. (C) The Pearson correlation r was calculated for the mRNA and
protein levels for six representative trisomic cell lines.
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Fig. 5. Protein levels of subunits of macromolecular complexes are attenuated in trisomic primary fibroblasts. (A) A heatmap of the average protein levels
per chromosome in primary fibroblasts. The experiments (columns) for each cell line are ordered by chromosome position. (B) A histogram of the average log2
ratios of the protein levels of genes located on chromosome 13 in trisomy 13 cell lines on chromosome 18 in trisomy 18 cell lines, on chromosome 21 in trisomy
21 cell lines in the first and second datasets, relative to euploid controls are shown. The bin size for all histograms is log2 ratio of 0.2. Fits to a normal dis-
tribution (black line), means, SD, and goodness of fit (R2) are shown for each distribution. (C) A histogram of the average log2 ratios of the RNA (red) and
protein (blue) levels of triplicated genes that show protein levels lower than predicted (Left) and 1.5-fold changes in trisomic fibroblasts. The bin size for all
histograms is log2 ratio of 0.1. Fits to a normal distribution (solid lines), means, SD, and goodness of fit (R
2) are shown for each distribution. (D) A few ex-
amples of individual subunits located on triplicated chromosomes that show attenuation at the protein levels compared to RNA. COG6 and RPL21 are in
chromosome 13. RPL17, ATP5F1A, and NDUFV2 are in chromosome18. ATP5PO, NDUFV3, and CCT8 are in chromosome 21. (E) The hierarchical clustering
analyses of proteome profiles do not cluster by karyotype of the cell lines.
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attenuated proteins). Consistent with previous studies in aneuploid
yeast cells, our findings in human cells indicate that protein levels
increase in abundance proportionally with mRNA levels, with a set
of proteins being attenuated by posttranscriptional mechanisms
most likely mediated by protein degradation pathways. Therefore, a
conserved consequence of aneuploidy in trisomy 21 cells is in-
creased protein synthesis leading to an imbalanced proteome and
higher activity of the protein quality control pathways.
Interindividual Variability Determines Proteome Profiles of Human
Primary Fibroblasts. As seen in the transcriptomes, hierarchical
clustering analysis demonstrates that the proteome profiles cluster
independent of karyotype (Fig. 5E). Several proteome profiles of
controls are more similar to trisomic proteomes than to other
controls. For example, the proteome profile of Con.2 is more
similar to T21.6, T21.7, and T21.2 than to the proteome of Con.1.
Importantly, we found a significant correlation between the pro-
teome profiles of the replicates within each dataset (Con.1a versus
Con.1b) and in between datasets (T21.1.1 versus T21.1.2), indi-
cating good reproducibility of our analysis.
Hierarchical clustering did not reveal a clear pattern of commonly
up- or down-regulated proteins in the aneuploid cell lines. Since
there is a strong correlation between RNA and protein changes,
we analyzed the protein levels of the down- and up-regulated gene
clusters identified in the transcriptome analyses (SI Appendix, Fig.
S5). Indeed, we found that these clusters also show specific down-
and up-regulation at the protein levels. However, analysis of the
average changes indicates that these responses are slightly atten-
uated. Importantly, this set of proteins remains enriched for fac-
tors that regulate amino acid biosynthesis in the down-regulated
cluster and DNA replication in the up-regulated cluster.
Trisomic Fibroblasts Rely on Serine-Driven Lipid Synthesis to Proliferate.
Altered sphingolipid metabolism is a conserved aneuploid-
associated phenotype of aneuploid yeast and mammalian cells
(13, 14, 30). Sphingolipids are essential molecules that are integral
structural components of cellular membranes. We recently showed
that altered sphingolipid levels are associated with abnormalities in
the morphology of the nucleus of aneuploid cells, including human
primary fibroblasts trisomic for chromosomes 13, 18, or 21 (13).
Furthermore, we found that sphingolipid levels in human trisomic
fibroblasts are elevated compared to euploid cells. The pathway of
the synthesis of sphingolipids is conserved in yeast and humans.
The initial step involves the condensation of the amino acid serine
to palmitoyl-CoA by serine palmitoyltransferase (SPT) to generate
long-chain bases (SI Appendix, Fig. S6). Analysis of the mRNA
levels of trisomic cell lines revealed that the expression of one of
the central subunits of SPT, SPTLC2, is up-regulated in several
trisomic fibroblasts cell lines compared to controls in our data set
(Fig. 6A). Notably, the SPTLC2 mRNA up-regulation is also
detected in several trisomy 21 cell lines analyzed in the Sullivan
et al. and Letourneau et al. studies (Fig. 6 A and B). The
SPTLC2 up-regulation could lead to increased SPT activity as
this subunit is essential for the stability of the enzyme (31). Con-
sistently, our proteome analyses indicate that the levels of SPTLC2
increase in trisomic fibroblasts compared to controls (Fig. 6C). We
performed Western blot analysis of SPTLC1 and SPTLC2 in 6
euploids and all 11 trisomic cell lines to validate these results. We
found that, indeed, the SPT protein levels increase in all trisomic
cell lines (Fig. 6D). These results provide a mechanism by which
sphingolipid synthesis is up-regulated in aneuploid cells (SI Ap-
pendix, Fig. S6). Furthermore, they suggest that the regulation of the
mRNA levels of one of the main subunits can stabilize the complex
and increase the cells’ enzyme levels.
Sphingolipid synthesis and levels are dependent on the avail-
ability of intracellular serine, and aneuploid yeast cells strictly
rely on serine synthesis to proliferate (14, 32). Here, we tested
whether trisomy fibroblasts rely on serine to proliferate.
Remarkably, we found that the proliferation rates of all 11 tri-
somic cell lines were significantly more affected than controls
when cells were cultured in a medium depleted of serine (Fig. 7 A
and B). On average, euploids slowed down and increased their
doubling times by 20% (2.1 to 2.6 d). Trisomic cell lines slowed
down by changing their doubling times from 40% in Tri21.2 up to
360% in Tri21.4. These results indicate that serine, an amino acid
utilized for protein, lipid, and nucleotide biosynthesis, is essential
for the proliferation of trisomy 21 cells. They also support the
hypothesis that aneuploidy disrupts cellular metabolism due to a
higher metabolic demand driven by increased nucleotide, protein,
and lipid synthesis.
Aneuploidy Lowers the Viability of Human Primary Fibroblasts. Pre-
vious studies have shown that mammalian trisomic cells prolif-
erate slower than their euploid counterparts (13, 25, 27, 33, 34),
an observation reported almost 50 y ago for trisomy 21 cells (35).
However, the mechanisms behind the slow proliferation pheno-
type remain unknown. Early passage trisomic cells show no signs
of cell cycle arrest or senescence as assayed by beta-galactosidase
staining. As reported in trisomic mouse embryonic fibroblasts
(MEFs) (33), we could not detect significant cell cycle delays in
human trisomic fibroblasts. Since cell cycle delays or senescence
do not account for lower proliferation rates of trisomic cells, and
because aneuploidy lowers viability in yeast (27), we tested
whether cell viability is affected in trisomic fibroblasts using the
LIVE/DEAD Fixable Green Dead Cell Stain Kit. This kit uses a
dye that reacts with free amines yielding intense fluorescent
staining. In viable cells, the dye’s reactivity is restricted to the cell
surface, resulting in less-intense fluorescence than in nonviable
cells where the dye diffuses inside the cell (SI Appendix, Fig. S7).
Remarkably, we found that human trisomic fibroblasts have a
significant increase in the population of nonviable cells. While
control cell lines show up 2% dead cells in their populations, the
trisomic cell lines show between 2 to 20% nonviable cells,
depending on their karyotype (Fig. 7 C and D). Such decreases in
viability can translate into a significant difference in cell numbers
during exponential growth. Phenotypic variation in cell viability
is noted among the seven trisomic 21 cell lines, as would be
expected from previous studies (36). Nevertheless, the lower
viability phenotype is significantly more pronounced in trisomies
13 and 18, consistent with the hypothesis that larger chromo-
somes are more deleterious to cell physiology than smaller ones.
Discussion
The acquisition of an extra autosome has detrimental conse-
quences to organismal development. Studies in yeast at the cel-
lular level indicate that the deleterious effects of aneuploidy
increase with the size of the extra chromosome (11, 27). In hu-
mans, three copies of chromosomes 21, 18, or 13, which encode
the least number of genes, in that order, are the only viable
trisomies. Notably, the effects on human development in triso-
mies 13 and 18 are more deleterious than in trisomy 21. This fact
is consistent with a correlation between the number of genes on
the triplicated chromosome and the degree by which aneuploidy
disrupts cellular physiology. In the context of Down syndrome, a
gene-centric view poses that increased expression of the tripli-
cated genes located on chromosome 21 causes cellular defects (3,
4). Our studies show that trisomy 21 cells share several pheno-
types with other mammalian aneuploid cells, including trisomic
MEFs, human trisomies 13 and 18, and even aneuploid yeast
cells (13, 25, 27, 33, 37). These aneuploidy-associated phenotypes
across organisms and independent of the triplicated chromosome
identity include hampered proliferation, genomic instability, ab-
normal nuclear morphology, and altered metabolism and proteo-
stasis. Therefore, one must consider the aneuploidy effects on cell
physiology to better understand the causes of the pathophysiology
associated with Down syndrome (Fig. 7E).
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Trisomies associated with sex chromosomes, such as the triple
X and XYY syndromes, are not as deleterious to human de-
velopment as autosomal trisomies. In triple X, the noncoding
RNA Xist silences the expression of the third copy of the X
chromosomes. Because the X chromosome is larger in sequence
than chromosomes 21, 18, or 13, its trisomy indicates that the
mere presence and maintenance of extra DNA are not signifi-
cant drivers of aneuploidy-associated phenotypes. In support of
this, yeast-harboring yeast artificial chromosomes with hetero-
chromatic human DNA comparable in size to the yeast chro-
mosomes do not show aneuploidy-associated phenotypes (14,
27). In the case of an extra copy of the Y chromosome, the
number of genes expressed and encoded on the Y chromosome
is significantly smaller than that of chromosome 21. Altogether,
these observations support the hypothesis that increases in gene
expression are the main cause for cellular imbalance and dis-
ruption of cellular homeostasis.
Several studies have suggested that dosage compensation
could ameliorate the RNA levels of the genes present on an
extra copy of an autosome (19, 38). However, mechanisms for
dosage compensation of an entire extra copy of an autosome are
not known in human cells. Here we show that, on average,
mRNA levels increase 1.5-fold in human cells trisomic for
chromosomes 13, 18, or 21, supporting a lack of dosage com-
pensation of human autosomes. Furthermore, quantitative pro-
teomics indicates that increases in transcript levels lead to
proportional increases in protein levels, except for a subset of
proteins that encode subunits of macromolecular complexes. As
evidenced in several studies, individual subunits of macromo-
lecular complexes are unstable unless they assemble into a stable
complex (24–26, 39). Excess subunits are either degraded or
aggregate since protein aggregation is also an effective mecha-
nism to lower extra proteins (39). Importantly, evolutionary
mechanisms are in place to synthesize and assemble subunits of a
particular complex in equimolar amounts, presumably sparing
the cell from the wasteful synthesis of individual subunits (40,
41). Secreted and membrane proteins are other classes of pro-
teins that show lower levels than the predicted 1.5-fold. The
secreted proteins will not accumulate in the cell but can lead to
physiological changes by modifying the extracellular environ-
ment. Membrane protein levels may depend on mechanisms that
control protein trafficking and endocytosis. Increased protein syn-
thesis, folding, and degradation may affect protein quality control
pathways and alter the metabolic demands of trisomy 21 cells, in-
dependent of the identity and function of the triplicated genes.
Analysis of different cell types from several individuals with or
without trisomy 21 indicates that transcriptome profiles cluster
independent of karyotype, sex, or age of the donor. Our analyses
of the transcriptomes of primary fibroblasts from several studies
indicate that each cell line uniquely expresses a set of tran-
scription factors associated with anatomical structure and de-
velopment. To circumvent this issue, Letourneau et al. analyzed
the expression pattern of two fibroblast cell lines isolated from
monozygotic twins, one of which has trisomy for chromosome 21.
Their studies concluded that trisomy 21 leads to genome-wide
disruption of chromosomal domains or territories. Two previous
publications questioned the findings by Letourneau et al. (42,
43). Our analysis indicates that the monozygotic cell lines display
noisy and nonreproducible gene expression profiles due to insuffi-
cient sequence coverage. Lastly, gene expression analyses of triso-
mic MEFs and human aneuploid cell lines generated by different
approaches do not converge to a unique gene expression pattern in
response to aneuploidy (25, 33, 44). In isogenic aneuploid yeast
strains, we showed that gene expression changes are associated with
slow proliferation (27). The fact that cell cycle delays are not pre-
sent in primary human cells is consistent with the lack of a tran-
scriptional response associated with slow proliferation.
Other aneuploidy-associated phenotypes in human trisomy
cells include increased replication stress measured by foci posi-
tive for the p53 Binding Protein 1 (13, 45). Mutations in genes
involved in DNA replication and repair cause premature aging
(46). Thus, aneuploidy-driven genomic instability may play an
active role in the premature aging characteristics of individuals
with Down syndrome. Importantly, trisomic MEFs and human
fibroblasts do not show significant defects in cell cycle progres-
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Fig. 6. Trisomic primary fibroblasts up-regulate the de novo synthesis of sphingolipids. (A) The expression levels of subunits SPTLC1 and SPTLC2 of the serine
palmitoyltransferase enzyme in fibroblasts in this study and in the Sullivan et al. (20) and Letourneau et al. (16) studies. (B) The expression levels of subunits
SPTLC1 and SPTLC2 in T cells and monocytes (20). (C) The protein levels of SPTLC1 and SPTLC2 in primary fibroblasts. (D) The Western blots of SPTLC1 and
SPTLC2 in primary fibroblasts. GADPH was used as a loading control.
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proliferation measured in cell accumulation assays is mainly due
to increased cell death in tissue culture. Interestingly, we did not
detect increases in caspase-3 cleavage, indicating cell death occurs
through noncanonical apoptosis or other cell death pathways. A
crucial question is whether lower cellular viability contributes to
abnormal human development associated with Down syndrome,
including reduced organ size (47).
The expression of the triplicated chromosome creates an in-
creased metabolic demand for the amino acid serine. As observed
in aneuploid yeast cells, we found that human trisomic cells rely on
serine to proliferate. Serine is a crucial amino acid used to make
glycine, and together, they account for a large proportion of the
codon usage in protein synthesis. Serine is also essential for nu-
cleotide and lipid biosynthesis (48). Several studies showed that
aneuploid yeasts, trisomic primary fibroblasts, and trisomic MEFs
have elevated levels of long-chain bases, the direct product of SPT
(13, 14, 30). Here, we found that trisomic human fibroblasts have
increased expression of SPT subunits. Long-chain bases are es-
sential components of the nuclear membrane, and cells harboring
an extra chromosome show abnormal nuclear morphologies. A
recent study of the metabolome profiles of plasma samples from
individuals with Down syndrome revealed serine and sphingosine-
1-phosphate, the main form of long-chain base in the blood, as the
top metabolites with lower abundance compared to control indi-
viduals (49). Because dietary serine can have significant conse-
quences on human physiology (50, 51), future research will
determine whether a serine-enriched diet could have beneficial
effects on the health of individuals with Down syndrome.
Experimental Procedures
Culture of Human Cell Lines. Primary human fibroblasts from euploid indi-
viduals and trisomy fibroblasts (SI Appendix, Fig. S1A) were purchased from
Coriell Cell Repositories. They were maintained in Minimum Essential Me-
dium (MEM, with nonessential amino acid; Gibco 10370088) supplemented
with 15% fetal bovine serum and 2 mM L-glutamine. To make serine/glycine-
depleted medium, MEM (Gibco 11095080) was supplemented with alanine,
asparagine, aspartic acid, glutamic acid, proline, and dialyzed serum (3-k
molecular weight cutoff).
RNASeq. Cells were grown for 48 h and 2 × 105 cells were harvested between
50 to 70% confluency. The RNAeasy Kit from Qiagen (catalog number
74104) was used to purify the RNA, and a nanoDrop was used to measure
concentration. Samples were shipped on dried ice for transcriptome se-
quencing to BGI Americas (https://www.bgi.com/). Paired-end reads were
aligned to human primary genome hg38, with star_2.5.3a 1, annotated with
GENECODE GRCh38.p12 annotation release 292. Aligned exon fragments with
mapping quality higher than 20 were counted toward gene expression
with featureCounts_1.5.2 3. Expression normalization was performed using
the TPM method (52–54). The parameters are as follows: genome,
hg38.primary.fa; GTF, gencode.v29.primary_assembly.annotation.gtf. The log2
ratios are presented in Dataset S1. The sequencing data are available at https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE154418.
RNAseq Data from Two Other Studies. Data from the Sullivan et al. study were
obtained from the public available database https://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE79842 and https://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE84531. Data from the Letourneau et al. study were
obtained from the public available database https://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE55426.
RNAseq Analysis. All RNAseq reads were normalized to the total number of
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Fig. 7. Trisomic primary fibroblasts rely on serine-driven lipid biosynthesis and show lower viability compared to euploid controls. (A) The proliferation of
control fibroblasts and trisomic fibroblasts with or without serine and glycine. The glycine was depleted because it can be used to generate serine by the
SHMT1/2 enzymes. The growth curves of four representative cell lines are shown. (B) Doubling times of primary fibroblasts were calculated in medium with
(blue bars) or without serine (red bars). A schematic of the experimental procedure is show above. The error bars represent SD, n = 3. (C, D) The viability assay
shows that there is an increase in cell death in the trisomic fibroblasts. Fluouresence-activated cell sorting is shown for four representative measurements, n =
5,000 cells (see SI Appendix, Fig. S7 for assay schematic and control experiment). In D, *P < 0.05 between trisome and average control, Student’s t test. (E) The
consequences of trisomy 21 in human cells are driven by gene- and aneuploidy-driven phenotypes.
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lines, the average TPM per gene was calculated for all the control euploid
samples and the average TPMwas used as a reference genome. Log2 (TPMper
gene/TPM of reference) was obtained for each sample. We included FC for
genes that were detected in all samples and a cutoff of 1 TPM or greater in
our analysis. Hierarchical clustering was performed using the program WCluster.
WCluster takes both a data table and a weight table to allow individual mea-
surements to be differentially considered by the clustering algorithm. Gene ex-
pression data were clustered by a Pearson correlation metric with equal
weighting given to all data, or with no weight given to genes on the triplicated
chromosomes. The PRISM software was used to calculate frequency distributions,
fit to a Gaussian curve, identify the outliers, perform linear regression analyses,
and calculate Pearson r correlation coefficients.
Western Blot Assay. Cells were lysed in lysis buffer (25 mM Tris HCl, pH = 7.5,
150 mM NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS), and
0.5% deoxycholate with protease inhibitors). Lysate was separated on SDS
polyacrylamide gels, and then proteins were transferred onto a polyvinylidene
difluoride membrane and analyzed with antibodies against SPTLC1 (Abcam,
ab176706), SPTLC2 (Abcam, ab23696), and GAPDH (Millipore, AB2302).
Immunoreactive signals were detected by the Super Signal reagent (Pierce).
Cell Proliferation Assay. A total of 1 × 104 cells were plated on 24-well plates
with the standard culture medium. After 8 h, cells were washed with phosphate-
buffered saline (PBS) and replaced with conditional medium with or without
serine/glycine (0.4 mM). Cell numbers were counted every 24 h for 6 d.
Cell Death Assay. To distinguish between live and dead cells, cells were stained
with LIVE/DEAD Fixable Dead Cell stain kit (Invitrogen, L34969). Briefly, 4 × 104
cells were plated on a 60-mM dish. After 4 d, detached cells were incubated with
fluorescent reactive dye at room temperature for 30 min in the dark. Stained
cells were washed with PBS and then fixed with PBS with 4% formaldehyde for
15 min. After washing cells with PBS, cells were resuspended in PBS with 1%
bovine serum albumin and analyzed the fixed-cell suspension by flow cytometry.
Plots in Fig. 7C were generated by FlowJo software.
Proteomics. See SI Appendix for detailed quantitative MS methodology.
Data Availability. RNAseq data of primary fibroblasts is publicly available at
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE154418 (61). Proteome
data are available at https://massive.ucsd.edu, ID number MSV000085706, and
are available for download at ftp://massive.ucsd.edu/MSV000085706.
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